ConductScience.org, home

Paper42345003

Treatment Approaches for Omalizumab-Refractory Chronic Spontaneous Urticaria.

Ensina LF and 5 others. J Inflamm Res, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Treatment Approaches for Omalizumab-Refractory Chronic Spontaneous Urticaria. Papers, record 42345003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42345003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment Approaches for Omalizumab-Refractory Chronic Spontaneous Urticaria.
PubMed
Journal
J Inflamm Res
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128543019The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU.Allergy2017https://conductscience.org/library/papers/28543019PubMed
231332983Factors Predicting the Response to Cyclosporin Treatment in Patients With Chronic Spontaneous Urticaria: A Systematic Review.Allergy Asthma Immunol Res2019https://conductscience.org/library/papers/31332983PubMed
339490777Endotypes, phenotypes, and biomarkers in chronic spontaneous urticaria: Evolving toward personalized medicine.Ann Allergy Asthma Immunol2025https://conductscience.org/library/papers/39490777PubMed
434650565What Basophil Testing Tells Us About CSU Patients - Results of the CORSA Study.Front Immunol2021https://conductscience.org/library/papers/34650565PubMed
536241154Existing and Investigational Medications for Refractory Chronic Spontaneous Urticaria: Safety, Adverse Effects, and Monitoring.J Allergy Clin Immunol Pract2022https://conductscience.org/library/papers/36241154PubMed
633496195Biomarkers of chronic spontaneous urticaria and their clinical implications.Expert Rev Clin Immunol2021https://conductscience.org/library/papers/33496195PubMed
735928809STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria.Front Immunol2022https://conductscience.org/library/papers/35928809PubMed
826483177Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria.J Allergy Clin Immunol2016https://conductscience.org/library/papers/26483177PubMed
930355455Identification of biomarkers for predicting the response to cyclosporine A therapy in patients with chronic spontaneous urticaria.Allergol Int2019https://conductscience.org/library/papers/30355455PubMed
1038433976D-dimer diagnostics: can I use any D-dimer assay? Bridging the knowledge-to-action gap.Res Pract Thromb Haemost2024https://conductscience.org/library/papers/38433976PubMed
1120626384Cyclosporine-A in severe chronic urticaria: the option for long-term therapy.Allergy2010https://conductscience.org/library/papers/20626384PubMed
1236448493Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances.Allergy2023https://conductscience.org/library/papers/36448493PubMed
1338431226Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials.J Allergy Clin Immunol2024https://conductscience.org/library/papers/38431226PubMed
1440756290A 10-Year Real-World Analysis of Omalizumab Use in Chronic Spontaneous Urticaria Patients at a Dermatology Clinic.Sisli Etfal Hastan Tip Bul2025https://conductscience.org/library/papers/40756290PubMed
1524522090Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.J Allergy Clin Immunol2014https://conductscience.org/library/papers/24522090PubMed
1611240971Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.Clin Pharmacol Ther2001https://conductscience.org/library/papers/11240971PubMed
1731494963Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis.Allergy2020https://conductscience.org/library/papers/31494963PubMed
1841005705Efficacy, Safety, and Quality-of-Life Outcomes of Remibrutinib in Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis.J Allergy Clin Immunol Pract2025https://conductscience.org/library/papers/41005705PubMed
1940682223Biomarkers of response to omalizumab in patients with chronic spontaneous urticaria.Allergol Immunopathol (Madr)2025https://conductscience.org/library/papers/40682223PubMed
2035853771Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?An Bras Dermatol2022https://conductscience.org/library/papers/35853771PubMed

See all 102 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IGHE3497PubTator's text mininghttps://conductscience.org/library/genes/3497NCBI Gene
KIT3815PubTator's text mininghttps://conductscience.org/library/genes/3815NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42345003

GET https://conductscience.org/api/papers/v1/42345003/references?page=2